Related references
Note: Only part of the references are listed.Mortality, intensive care treatment, and cost evaluation: Role of a polymerase chain reaction assay in patients with sepsis
Markota Andrej et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities
Giuseppe Lippi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Effect of Procalcitonin Testing on Health-care Utilization and Costs in Critically Ill Patients in the United States
Robert A. Balk et al.
CHEST (2017)
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
CRITICAL CARE MEDICINE (2017)
Antimicrobial Resistance
Hilary D. Marston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis
Marie Westwood et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Konrad Reinhart et al.
CLINICAL MICROBIOLOGY REVIEWS (2012)
Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors
KL Becker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial
M Christ-Crain et al.
LANCET (2004)
Share Paper
